Ovitrelle 250 µg
Ovitrelle 250 µg is a medicine authorised by Swissmedic under authorisation number 56364. The authorisation holder is Merck (Schweiz) AG. The medicinal product code is Biotechnological medicines and the dispensing category is A: Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly. First authorisation was granted on 17 February 2004 and the authorisation is valid without a time limit. ATC code G03GA08 places the medicine in the group Sex hormones and modulators of the genital system.
| Authorisation number | 56364 |
|---|---|
| Name | Ovitrelle 250 µg |
| Full name | Ovitrelle 250 µg, Injektionslösung in einer Fertigspritze |
| Authorisation holder | Merck (Schweiz) AG |
| Medicinal product code | Biotechnological medicines |
| Dispensing category | A · Prescription, not repeatable |
| ATC code | G03GA08 |
| First authorisation | 17 February 2004 |
| Authorisation validity | unlimited |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Ovitrelle 250 µg, Injektionslösung in einer Fertigspritze | A | 17 February 2004 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 7 | 1 | Spritze(n) | G03GA08 | 07.08.1. | A |
Scroll the table sideways
Other medicines from this authorisation holder
Frequently asked questions
Is Ovitrelle 250 µg authorised in Switzerland?
Yes. Ovitrelle 250 µg is authorised by Swissmedic under authorisation number 56364, data as of 01 September 2026. The authorisation is valid without a time limit.
Which dispensing category does Ovitrelle 250 µg have?
Ovitrelle 250 µg is in dispensing category A. Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly.
Who is the authorisation holder of Ovitrelle 250 µg?
The authorisation holder is Merck (Schweiz) AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.